LGVN
$3.54
Longeveron
$.03
.85%
LGVN
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.26)
Revenue:  $0.40 Mil
Friday
Aug 11
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LGVN reports earnings?
Beat
Meet
Miss

Where is LGVN's stock price going from here?
Up
Flat
Down
Stock chart of LGVN
Analysts
Summary of analysts' recommendations for LGVN
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.
›